| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/28/2002 | WO2002016350A1 Amine derivatives |
| 02/28/2002 | WO2002016349A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 02/28/2002 | WO2002016348A1 Antiangiogenic bicyclic derivatives |
| 02/28/2002 | WO2002016347A1 Active metabolite of gepirone |
| 02/28/2002 | WO2002016338A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/28/2002 | WO2002015909A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | WO2001087887A3 Neuroprotective and anti-proliferative compounds |
| 02/28/2002 | WO2001085699A3 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/28/2002 | WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/28/2002 | WO2001077080A3 Pyrazole compounds having anti proliferative activity |
| 02/28/2002 | WO2001064639A3 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 02/28/2002 | WO2001056989A3 Inhibitors of factor xa |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026056 Substituted imidazoles having cytokine inhibitory activity |
| 02/28/2002 | US20020026054 Antihistaminic activity, anti-allergic activity |
| 02/28/2002 | US20020026052 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease |
| 02/28/2002 | US20020025967 Antiserotinone agents |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/28/2002 | US20020025963 Novel guanidine mimics as factor Xa inhibitors |
| 02/28/2002 | US20020025961 Platelet ADP receptor inhibitors |
| 02/28/2002 | US20020025957 Anticoagulants, cardiovascular disorders |
| 02/28/2002 | US20020025955 Substituted lactams as inhibitors of A beta protein production |
| 02/28/2002 | US20020025948 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 02/28/2002 | US20020025342 Novel administration form comprising an acid-labile active compound |
| 02/28/2002 | DE10040525A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | CA2419266A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 02/28/2002 | CA2415846A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/27/2002 | EP1182202A1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 02/27/2002 | EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders |
| 02/27/2002 | EP1181287A1 Sulfonamide compounds with pharmaceutical activity |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181270A2 Inhibitors of factor xa |
| 02/27/2002 | EP1181017A1 Metalloprotease inhibitors |
| 02/27/2002 | EP0927178B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/27/2002 | EP0790982B1 Methods of synthesis of peptidyl argininals |
| 02/27/2002 | EP0783495B1 Quinoxaline derivatives useful in therapy |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | CN1337960A Piperdine and piperazine derivatives as inhibitors of the ABETA fibril formation |
| 02/27/2002 | CN1337959A 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337950A 2-oxoquinoline compounds and medicinal uses thereof |
| 02/27/2002 | CN1337851A Converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/27/2002 | CN1079794C Ether compound, use thereof, and intermediate for producing the compound |
| 02/27/2002 | CN1079793C Process for preparation of enantiomerically pure substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 02/26/2002 | US6350876 4-chloro-3,5-dimethyl-2-sulfonyl pyridines |
| 02/26/2002 | US6350771 Pesticidal 1-arylpyrazoles |
| 02/26/2002 | US6350770 Microbiocides, insecticides |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | US6350766 Pain, cns |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350763 Small molecules useful in the treatment of inflammation disease |
| 02/26/2002 | US6350762 Dihydropyridine derivative |
| 02/26/2002 | US6350760 Substituted piperidines as melanocortin-4 receptor agonists |
| 02/26/2002 | US6350759 Dihydro- and tetrahydro-quinoline compounds |
| 02/26/2002 | US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350746 Benzamidine derivatives and their use as anti-coagulants |
| 02/26/2002 | US6350744 Pyrmidine or pyridine derivatives; antiarthritic and antiinflammatory agents; cachexia treatment; interleukin and tumor necrosis factor inhibitors |
| 02/26/2002 | US6350479 Treating depression with alcohol extracts of tobacco |
| 02/26/2002 | CA2284470C New crystalline form of omeprazole |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2160966C Piperidine derivatives; process for preparing them and compositions containing the same |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/21/2002 | WO2002014315A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 02/21/2002 | WO2002014308A1 Antithrombotic agents |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014283A1 Processes for preparing cilostazol |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014277A1 Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof |
| 02/21/2002 | WO2002014273A1 Indoline derivatives as 5ht2c antagonists |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors |
| 02/21/2002 | WO2002014269A2 2,4-substituted pyridine derivatives |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001068609B1 1,2,3,4-tetrahydroisoquinoline derivatives |
| 02/21/2002 | WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001019791A3 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 02/21/2002 | US20020022642 As nitric oxide synthase (NOS) inhibitors, used in therapy and prophylaxis of central nervous system disorders, inflammatory disorders, septic shock and other disorders |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022627 Inhibition of cyclooxygenase-2activity |
| 02/21/2002 | US20020022624 Azaindole derivatives and their use as therapeutic agents |
| 02/21/2002 | US20020022617 Methods for increasing nitric oxide synthase activity |
| 02/21/2002 | US20020022614 Thrombin or factor Xa inhibitors |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |